Evidence map›Paper›PMID 24297389›Full record

SynthesisThe Cochrane database of systematic reviews2013

Antibiotics for preterm rupture of membranes.

Sara Kenyon, Michel Boulvain, James P Neilson

4 registry-linked trialsOpen access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in The Cochrane database of systematic reviews, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 4 registered trials, which are not on this map. Cited by 57 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 6 pooled it
29.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02314728 nacompletednot on this mapstarted 2014, after this paper: background citation

Cervical Ripening in Premature Rupture of Membranes

TypeinterventionalSponsorMontefiore Medical CenterRan2014 to 2016Enrolled230ConditionsPregnancy, Premature Rupture of Membranes, Preterm Premature Rupture of Membranes, Unfavorable CervixArmsMisoprostol, Oxytocin
NCT02819570 phase4unknown statusnot on this mapstarted 2015, after this paper: background citation

Comparison of Two Antibiotic Prophylactic Protocols in Preterm Premature Rupture of the Membranes. A Randomized Prospective, Open Trial

TypeinterventionalSponsorWestern Galilee Hospital-NahariyaRan2015 to 2017Enrolled400ConditionsPremature Rupture of MembraneArmsI.V cefuroxime 750 mg*3/d for 2 days, I.V ampicillin 2 gram x4/d for 2 days, P.O cefuroxime 500 mgx2/d for 5 days, P.O roxithromycin 150 mg*2/d for 7 days, P.O moxypen 500 mgx3/d for 5 days
NCT05328817 naunknown statusnot on this mapstarted 2022, after this paper: background citation

Azithromycin Versus Erythromycin For Preterm Prelabor Rupture of Membranes: A Randomized Controlled Trial

TypeinterventionalSponsorEastern Virginia Medical SchoolRan2022 to 2025Enrolled240ConditionsPreterm Premature Rupture of MembraneArmsAntibiotics
NCT05345457 phase4terminatednot on this mapstarted 2023, after this paper: background citation

Outpatient Antibiotics Following Previable Rupture of Membranes (pPPROM) Between 18 0/7 and 22 6/7 Weeks Gestational Age

TypeinterventionalSponsorUniversity Hospitals Cleveland Medical CenterRan2023 to 2024Enrolled1ConditionsPregnancy Preterm, Pregnancy Prom, PROM, Preterm (Pregnancy), PROM (Pregnancy)ArmsAzithromycin Pill, Amoxicillin Pill
3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 6 syntheses or guidelines pooled it, 535 citations in OpenAlex.

  1. Guideline
  2. Pooled it
  3. Guideline
  4. Guideline
  5. Pooled it
  6. Antibiotic regimens for management of intra-amniotic infection.The Cochrane database of systematic reviews · 2014
    Pooled it
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. PlacingChildren (Basel, Switzerland) · 2023
    Article
  19. Safety of Antimicrobials for Postexposure Prophylaxis and Treatment of Anthrax: A Review.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Review
  20. Preterm Birth Therapies to Target Inflammation.Journal of clinical pharmacology · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sara KenyonSchool of Health and Population Sciences, University of Birmingham, Public Health Building, Edgbaston, UK, B15 2TT.
Michel Boulvain
James P Neilson
University of Birmingham · GBUniversity of Liverpool · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPremature birth carries substantial neonatal morbidity and mortality. Subclinical infection is associated with preterm rupture of membranes (PROM). Prophylactic maternal antibiotic therapy might lessen infectious morbidity and delay labour, but could suppress labour without treating underlying infection.

objectivesTo evaluate the immediate and long-term effects of administering antibiotics to women with PROM before 37 weeks, on maternal infectious morbidity, neonatal morbidity and mortality, and longer-term childhood development. SEARCH

methodsWe searched the Cochrane Pregnancy and Childbirth Group's Trials Register (30 September 2013). SELECTION CRITERIA: Randomised controlled trials comparing antibiotic administration with placebo that reported clinically relevant outcomes were included as were trials of different antibiotics. Trials in which no placebo was used were included for the outcome of perinatal death alone. DATA COLLECTION AND ANALYSIS: We extracted data from each report without blinding of either the results or the treatments that women received. We sought unpublished data from a number of authors. MAIN

resultsWe included 22 trials, involving 6872 women and babies.The use of antibiotics following PROM is associated with statistically significant reductions in chorioamnionitis (average risk ratio (RR) 0.66, 95% confidence interval (CI) 0.46 to 0.96, and a reduction in the numbers of babies born within 48 hours (average RR 0.71, 95% CI 0.58 to 0.87) and seven days of randomisation (average RR 0.79, 95% CI 0.71 to 0.89). The following markers of neonatal morbidity were reduced: neonatal infection (RR 0.67, 95% CI 0.52 to 0.85), use of surfactant (RR 0.83, 95% CI 0.72 to 0.96), oxygen therapy (RR 0.88, 95% CI 0.81 to 0.96), and abnormal cerebral ultrasound scan prior to discharge from hospital (RR 0.81, 95% CI 0.68 to 0.98). Co-amoxiclav was associated with an increased risk of neonatal necrotising enterocolitis (RR 4.72, 95% CI 1.57 to 14.23).One study evaluated the children's health at seven years of age (ORACLE Children Study) and found antibiotics seemed to have little effect on the health of children. AUTHORS'

conclusionsRoutine prescription of antibiotics for women with preterm rupture of the membranes is associated with prolongation of pregnancy and improvements in a number of short-term neonatal morbidities, but no significant reduction in perinatal mortality. Despite lack of evidence of longer-term benefit in childhood, the advantages on short-term morbidities are such that we would recommend antibiotics are routinely prescribed. The antibiotic of choice is not clear but co-amoxiclav should be avoided in women due to increased risk of neonatal necrotising enterocolitis.

Indexed as

Amoxicillin-Potassium Clavulanate CombinationAnti-Bacterial AgentsChildChorioamnionitisDevelopmental DisabilitiesFemaleHumansInfant, NewbornInfant, PrematureLength of StayMacrolidesPerinatal MortalityPregnancyPregnancy Complications, InfectiousPremature BirthPremature Rupture of Fetal MembranesAmoxicillin-Potassium Clavulanate CombinationAnti-Bacterial AgentsMacrolides

Identifiers

PMID24297389
PMCPMC11297390
OpenAlexW2118026870

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.